Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Motorola Solutions Inc (MSI) Price & Performance

Heron Therapeutics IncTrade
Motorola Solutions IncTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Motorola Solutions Inc — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while Motorola Solutions Inc trades at $410.4 (market cap $68.13B). The key difference: Motorola Solutions Inc is far larger — about 744.9× Heron Therapeutics Inc's market cap, and Motorola Solutions Inc pays a 1.18% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

HRTXMSI
Market Cap
$91.46M$68.13B
Sector
HealthTechnology
52-Week High
$1.96$490.30
52-Week Low
$0.39$363.83
Enterprise Value
$189.36M$76.83B
Dividend Yield
1.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

Motorola Solutions Inc

MSI trades at $412.34, down 0.23% on the day, with a neutral technical signal. The company shows strong profitability with a 17.61% net income margin and has beaten earnings estimates for three consecutive quarters. Recent developments include the $1.5 billion acquisition of D-Fend Solutions and expansion of AI capabilities for emergency response systems, indicating strategic growth in public safety technology.

The outlook remains positive with a consensus price target of $512.33, representing 24% upside potential. Key risks include high valuation multiples and significant investing cash outflows from acquisitions. Analyst sentiment is bullish with 70.59% buy ratings, though investors should monitor integration execution of recent deals and competitive pressures in the tech sector.

Returns comparison

Trailing returns across standard periods

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About Motorola Solutions Inc

Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.

Read more on MSI